Last10K.com

Abraxis Bioscience, Inc. (1409012) SEC Filing 8-K Material Event for the period ending Wednesday, February 3, 2010

Abraxis Bioscience, Inc.

CIK: 1409012

View differences made from one to another to evaluate Abraxis Bioscience, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abraxis Bioscience, Inc..

Continue

Assess how Abraxis Bioscience, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abraxis Bioscience, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
CIK: 1409012
Form Type: 8-K Corporate News
Accession Number: 0001193125-10-022613
Submitted to the SEC: Fri Feb 05 2010 6:05:06 AM EST
Accepted by the SEC: Fri Feb 05 2010
Period: Wednesday, February 3, 2010
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1409012/0001193125-10-022613.htm